GSK and Sanofi accomplice to create antibody against covid-19 Kumar Jeetendra | April 14, 2020 In an uncommon coordinated effort, French biopharmaceutical company Sanofi and its British opponent GlaxoSmithKline plc (GSK) have banded together to build up an immunization against covid-19, which if fruitful, will be popularized in the second 50% of one year from now, the French firm said in a discharge. “This cooperation unites two of the world’s …
You should know what is Aarogya Setu application, how it helps battle coronavirus Kumar Jeetendra | April 14, 2020 Prime minister Narendra Modi in his speech to the country on Tuesday morning asked to download the ‘Aarogya Setu App’. Thus, we should comprehend what this application is about. This application is intended to help control the spread of coronavirus and make its data open to the ordinary citizens. This unique application additionally helps in …
Dr Reddy’s introduces generic cancer drug Invista in india Kumar Jeetendra | April 13, 2020 Pharma major Dr Reddy’s Laboratories Ltd has propelled Invista. It is a detailing of Dasatinib that is bioequivalent to the pioneer brand. Patent on Dasatinib is possessed by Bristol-Myers-Squibb. The Indian patent has lapsed on April 12, 2020. It is demonstrated for the treatment of ceaseless quickened or myeloid or lymphoid impact stage and recently …
Cipla receives final approval for generic version of inhalation drug Kumar Jeetendra | April 9, 2020 Mumbai, India; April 9, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA). Cipla’s Albuterol Sulfate Inhalation Aerosol …
West Pharmaceutical Names Stewart Campbell Vice President & General Manger for Asia Pacific Region Kumar Jeetendra | April 8, 2020 West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President & General Manager for the Asia Pacific region. Stewart brings more than 25 years of organizational leadership in the food, pharmaceutical and dietary supplement industries, with extensive Asia Pacific management expertise. …
World First Clinical Study of iPSC-derived Corneal Epithelial Cells Kumar Jeetendra | April 6, 2020 AMSBIO report on a world first clinical study of iPSC-derived corneal epithelial cells by Professor Ryuhei Hayashi and co-workers from the Graduate School of Medicine, Osaka University, Japan using StemFit Basic03 clinical grade stem cell culture medium and iMatrix-511 recombinant laminin E8 fragments. In this ground-breaking work, corneal epithelial sheets from HLA-homozygous iPS cells were …
Cipla reports fruitful completion of Phase-3 clinical examination for generic version of GSK’s Advair Diskus® Kumar Jeetendra | April 2, 2020 Cipla Limited today declared the fruitful completion of Phase-3 clinical end-point concentrate for fluticasone propionate and salmeterol inward breath powder (100/50 mcg). Fluticasone propionate and salmeterol inward breath powder 100/50 mcg, 250/50 mcg and 500/50 mcg are nonexclusive adaptations of GSK’s Advair Diskus®. The item is shown to treat asthma in patients 4 years and …
Danaher finishes procurement of GE Healthcare’s Life Sciences division Kumar Jeetendra | April 1, 2020 New Danaher working organization made after fruition of $21.4B securing by Danaher Corporation – Previously GE Healthcare Life Sciences, Cytiva will help quicken development and advancement in natural treatments – Leading life sciences brands, for example, ÄKTA, Amersham, HyClone, MabSelect and Whatman are a piece of Cytiva Cytiva, a worldwide supplier of innovations and administrations …
Intas to give 2 million hydroxychloroquine tablets to WHO focus on COVID-19 Kumar Jeetendra | March 30, 2020 Intas Pharmaceuticals Ltd. has said it will give up to 2,000,000 tablets of hydroxychloroquine to World Health Organization-supported examination into the avoidance of COVID-19 contamination utilizing hydroxychloroquine, for nothing out of pocket, alongside 2,000,000 tablets of coordinated fake treatment. Intas educated that it is teaming up on the WHO-embraced study utilizing hydroxychloroquine, a medication that …
Malaria drug is greatest expectation against coronavirus-Novartis CEO Kumar Jeetendra | March 29, 2020 Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit’s jungle fever, lupus and joint pain tranquilize hydroxychloroquine is the organization’s greatest expectation against the coronavirus, Swiss paper SonntagsZeitung gave an account of Sunday. Novartis has vowed to give 130 million dosages and is supporting clinical preliminaries required before the medication, which U.S. President Donald …
Restrictions on export of key Malaria drug in the midst of coronavirus episode Kumar Jeetendra | March 25, 2020 The Indian government said on Wednesday that it is forbidding the fare of hydroxychloroquine and plans produced using the medicine, as specialists test the viability of the medication in helping treat patients contaminated with Covid-19. There are at present no endorsed medications, or preventive immunizations for Covid-19, the profoundly infectious, once in a while savage …
First Made-in-India COVID-19 test pack by Mylab gets business endorsement Kumar Jeetendra | March 23, 2020 Pune-based sub-atomic diagnostics organization Mylab Discovery Solutions Pvt Ltd, which spends significant time in sub-atomic analytic units has grown originally made-in-India test pack for COVID-19 of every a record time of about a month and a half. The unit – Mylab PathoDetect COVID-19 Qualitative PCR pack – is the first to get business endorsement from …
